Regulon

Regulon: R-2504

Regulons are regulatory units consisting of a coherently expressed set of genes and the associated regulator(s) whose binding site(s) they share.

Regulon Summary

Regulon summary table displays all associated information related to the specific regulon including the number of genes in the regulon, Hazard ratio, its Regulator, the Transcriptional Program that includes the regulon, Drugs that are associated with members of the regulon, together with mechanism of action and class, and enriched hallmarks of cancer if any.

GenesCox Hazard RatioRegulatorsCausal FlowsTranscriptional ProgramsHallmarks
72.1050718Pr-108Self sufficiency in growth signalInsensitivity to antigrowth signalEvading apoptosisSustained angiogenesisTissue invasion and metastasisTumor-promoting inflammationReprogramming energy metabolismEvading immune detectionLimitless replicative potentialGenome instability and mutation

Regulon Genes

List of genes that are included in the regulon. These genes have similar expression profiles in subset of patients and they share common binding motif for the Regulator of the regulon. Clicking on the gene name will take you to the gene specific page with more details. Please wait while information is collated from several resources after you click.

Entrez IDEnsEMBL IDPreferred NameUniprot ID
1183 ENSG00000073464 CLCN4 P51793
54472 ENSG00000078902 TOLLIP Q9H0E2
5595 ENSG00000102882 MAPK3 P27361
7533 ENSG00000128245 YWHAH Q04917
23710 ENSG00000139112 GABARAPL1 Q9H0R8
6844 ENSG00000220205 VAMP2 P63027
80212 ENSG00000275035 CCDC92 F5H7P8

Regulon Drugs

NameApproved SymbolTypeAction TypeMechanism of ActionMax Trial PhaseMax GBM Phase
TEMUTERKIBMAPK3Small moleculeINHIBITORMitogen-activated protein kinase; ERK1/ERK2 inhibitor20
MK-8353MAPK3Small moleculeINHIBITORMAP kinase ERK1 inhibitor10
ULIXERTINIBMAPK3Small moleculeINHIBITORMAP kinase ERK2 inhibitor20
KO-947MAPK3Small moleculeINHIBITORMitogen-activated protein kinase; ERK1/ERK2 inhibitor10
BOTULINUM TOXIN TYPE BVAMP2UnknownINHIBITORVesicle-associated membrane protein 2 inhibitor40
RAVOXERTINIBMAPK3Small moleculeINHIBITORMAP kinase ERK2 inhibitor10

Causal Flows

Causal Flows are statistically significant links between putative causal events (somatic mutations, copy number variations, chromosomal translocations, etc.) and the activity levels of regulators and regulons. In the causal flow a mutation may causally activates or deactivates a downstream regulator which then might up- or down-regulates a regulon that contains genes with similar expression profiles and binding sites.

Causal Mechanistic Flows for Regulon R-2504

IDMutationRoleRegulatorRoleRegulon# downstream regulons# diffexp regulonsDrugs
CMF-03456AK7up-regulatesSREBF1activatesR-2504121Drugs (6)

Regulator Drugs (0)

Regulon Drugs (6)

TEMUTERKIB, MK-8353, ULIXERTINIB, KO-947, BOTULINUM TOXIN TYPE B, RAVOXERTINIB

CMF-03753DSPup-regulatesSREBF1activatesR-2504123Drugs (6)

Regulator Drugs (0)

Regulon Drugs (6)

TEMUTERKIB, MK-8353, ULIXERTINIB, KO-947, BOTULINUM TOXIN TYPE B, RAVOXERTINIB

CMF-04832NEFMup-regulatesSREBF1activatesR-2504122Drugs (6)

Regulator Drugs (0)

Regulon Drugs (6)

TEMUTERKIB, MK-8353, ULIXERTINIB, KO-947, BOTULINUM TOXIN TYPE B, RAVOXERTINIB

CMF-05868ZNF813down-regulatesSREBF1activatesR-2504121Drugs (6)

Regulator Drugs (0)

Regulon Drugs (6)

TEMUTERKIB, MK-8353, ULIXERTINIB, KO-947, BOTULINUM TOXIN TYPE B, RAVOXERTINIB

CMF-15365DSEup-regulatesSREBF1activatesR-2504125Drugs (6)

Regulator Drugs (0)

Regulon Drugs (6)

TEMUTERKIB, MK-8353, ULIXERTINIB, KO-947, BOTULINUM TOXIN TYPE B, RAVOXERTINIB

CMF-15925OR13C8down-regulatesSREBF1activatesR-2504121Drugs (6)

Regulator Drugs (0)

Regulon Drugs (6)

TEMUTERKIB, MK-8353, ULIXERTINIB, KO-947, BOTULINUM TOXIN TYPE B, RAVOXERTINIB

CMF-23682TP53down-regulatesSREBF1activatesR-25041211Drugs (6)

Regulator Drugs (0)

Regulon Drugs (6)

TEMUTERKIB, MK-8353, ULIXERTINIB, KO-947, BOTULINUM TOXIN TYPE B, RAVOXERTINIB

CMF-25025IQSEC3down-regulatesSREBF1activatesR-2504128Drugs (6)

Regulator Drugs (0)

Regulon Drugs (6)

TEMUTERKIB, MK-8353, ULIXERTINIB, KO-947, BOTULINUM TOXIN TYPE B, RAVOXERTINIB